Literature DB >> 6361804

Cellular pharmacokinetics of the phenylalanine mustards.

D T Vistica.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6361804     DOI: 10.1016/0163-7258(83)90009-8

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  16 in total

1.  Antineoplastic efficacy of melphalan and N-(2-chloroethyl)-N-nitrosocarbamoyl-omega-lysine, in combination with diazoxide or insulin in autochthonous mammary carcinoma of the Sprague-Dawley rat.

Authors:  T Klenner; M R Berger; O Zelezny; M Fink; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  The pharmacokinetics of melphalan during intermittent therapy of multiple myeloma.

Authors:  U Loos; E Musch; M Engel; J H Hartlapp; E Hügl; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.

Authors:  N H Greig; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

4.  Effect of L-leucine on oral melphalan kinetics in patients.

Authors:  P A Reece; B M Dale; R G Morris; D Kotasek; D Gee; S Rogerson; R E Sage
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.

Authors:  S C Mann; P A Andrews; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier.

Authors:  Y Takada; N H Greig; D T Vistica; S I Rapoport; Q R Smith
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Renal clearance and protein binding of melphalan in patients with cancer.

Authors:  P A Reece; H S Hill; R M Green; R G Morris; B M Dale; D Kotasek; R E Sage
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  The effect of food on oral melphalan absorption.

Authors:  P A Reece; D Kotasek; R G Morris; B M Dale; R E Sage
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Glutathione is required for intestinal function.

Authors:  J Mårtensson; A Jain; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

10.  Degradation of melphalan in vitro: rationale for the use of continuous exposure in chemosensitivity assays.

Authors:  A G Bosanquet; M C Bird
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.